These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 39067682)
1. Cell-specific expression of Cre recombinase in rat noradrenergic neurons via CRISPR-Cas9 system. Yu J; Ji S; Tao H; Shan X; Yan Y; Sun X; Tu X; Li L; Deng C Neuroscience; 2024 Sep; 556():31-41. PubMed ID: 39067682 [TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated targeting of the Rosa26 locus produces Cre reporter rat strains for monitoring Cre-loxP-mediated lineage tracing. Ma Y; Yu L; Pan S; Gao S; Chen W; Zhang X; Dong W; Li J; Zhou R; Huang L; Han Y; Bai L; Zhang L; Zhang L FEBS J; 2017 Oct; 284(19):3262-3277. PubMed ID: 28763160 [TBL] [Abstract][Full Text] [Related]
3. Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT. Stubbusch J; Majdazari A; Schmidt M; Schütz G; Deller T; Rohrer H Genesis; 2011 Dec; 49(12):935-41. PubMed ID: 21634003 [TBL] [Abstract][Full Text] [Related]
4. Generation of Two Noradrenergic-Specific Dopamine-Beta-Hydroxylase-FLPo Knock-In Mice Using CRISPR/Cas9-Mediated Targeting in Embryonic Stem Cells. Sun JJ; Ray R PLoS One; 2016; 11(7):e0159474. PubMed ID: 27441631 [TBL] [Abstract][Full Text] [Related]
6. In vivo cell type-specific CRISPR knockdown of dopamine beta hydroxylase reduces locus coeruleus evoked wakefulness. Yamaguchi H; Hopf FW; Li SB; de Lecea L Nat Commun; 2018 Dec; 9(1):5211. PubMed ID: 30523254 [TBL] [Abstract][Full Text] [Related]
7. Inducible gene manipulations in brain serotonergic neurons of transgenic rats. Weber T; Schönig K; Tews B; Bartsch D PLoS One; 2011; 6(11):e28283. PubMed ID: 22140568 [TBL] [Abstract][Full Text] [Related]
8. Specific uptake and retrograde flow of antibody to dopamine-beta-hydroxylase by central nervous system noradrenergic neurons in vivo. Silver MA; Jacobowitz DM Brain Res; 1979 May; 167(1):65-75. PubMed ID: 88246 [TBL] [Abstract][Full Text] [Related]
9. Building Cre Knockin Rat Lines Using CRISPR/Cas9. Ma Y; Zhang L; Huang X Methods Mol Biol; 2017; 1642():37-52. PubMed ID: 28815492 [TBL] [Abstract][Full Text] [Related]
10. Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. McMillan PJ; White SS; Franklin A; Greenup JL; Leverenz JB; Raskind MA; Szot P Brain Res; 2011 Feb; 1373():240-52. PubMed ID: 21147074 [TBL] [Abstract][Full Text] [Related]
11. Restoration of Noradrenergic Function in Parkinson's Disease Model Mice. Cui K; Yang F; Tufan T; Raza MU; Zhan Y; Fan Y; Zeng F; Brown RW; Price JB; Jones TC; Miller GW; Zhu MY ASN Neuro; 2021; 13():17590914211009730. PubMed ID: 33940943 [TBL] [Abstract][Full Text] [Related]
12. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease. Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457 [TBL] [Abstract][Full Text] [Related]
13. Demonstration of two separate descending noradrenergic pathways to the rat spinal cord: evidence for an intragriseal trajectory of locus coeruleus axons in the superficial layers of the dorsal horn. Fritschy JM; Grzanna R J Comp Neurol; 1990 Jan; 291(4):553-82. PubMed ID: 2329191 [TBL] [Abstract][Full Text] [Related]
14. Central noradrenergic lesioning using anti-DBH-saporin: anatomical findings. Wrenn CC; Picklo MJ; Lappi DA; Robertson D; Wiley RG Brain Res; 1996 Nov; 740(1-2):175-84. PubMed ID: 8973812 [TBL] [Abstract][Full Text] [Related]
15. Catecholaminergic cell type-specific expression of Cre recombinase in knock-in transgenic rats generated by the Combi-CRISPR technology. Matsushita N; Nishizawa K; Kato S; Iguchi Y; Fukabori R; Takeuchi K; Miyasaka Y; Mashimo T; Kobayashi K J Neurosci Methods; 2022 Nov; 381():109707. PubMed ID: 36089167 [TBL] [Abstract][Full Text] [Related]
16. Projections from the rat cuneiform nucleus to the A7, A6 (locus coeruleus), and A5 pontine noradrenergic cell groups. Bajic D; Proudfit HK J Chem Neuroanat; 2013 May; 50-51():11-20. PubMed ID: 23524296 [TBL] [Abstract][Full Text] [Related]
17. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons. Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090 [TBL] [Abstract][Full Text] [Related]
18. A Cre-Dependent CRISPR/dCas9 System for Gene Expression Regulation in Neurons. Carullo NVN; Hinds JE; Revanna JS; Tuscher JJ; Bauman AJ; Day JJ eNeuro; 2021; 8(4):. PubMed ID: 34321217 [TBL] [Abstract][Full Text] [Related]
19. Sex-specific acclimation of A2 noradrenergic neuron dopamine-β-hydroxylase and estrogen receptor variant protein and 5'-AMP-Activated protein kinase reactivity to recurring hypoglycemia in rat. Briski KP; Ali MH; Napit PR J Chem Neuroanat; 2020 Nov; 109():101845. PubMed ID: 32599255 [TBL] [Abstract][Full Text] [Related]
20. Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents: linking stress-integrative circuitry. Kravets JL; Reyes BA; Unterwald EM; Van Bockstaele EJ Brain Struct Funct; 2015 Jan; 220(1):541-58. PubMed ID: 24271021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]